Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)
Takashi Muramatsu(Chiba University), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Shengxian Tu(Shanghai Jiao Tong University), Nozomi Kotoku(St. Marianna University School of Medicine), Yosuke Miyazaki(Yamaguchi University), Shinichiro Masuda(Iwate Medical University), Norihiro Kogame(Amsterdam UMC Location University of Amsterdam), Masato Nakamura(Toho University), Scot Garg(East Lancashire Hospitals NHS Trust), Kai Ninomiya(Ollscoil na Gaillimhe – University of Galway), Gaku Nakazawa(Kindai University), Taku Asano(Amsterdam UMC Location University of Amsterdam), Hiroshi Takahashi(University of Tsukuba), Patrick W. Serruys(Erasmus MC), Shigetaka Kageyama(Ollscoil na Gaillimhe – University of Galway), Ken Kozuma(Teikyo University Hospital), Kuniaki Takahashi(University of Amsterdam), Hideyuki Kawashima(Teikyo University), Yuki Ishibashi(Erasmus University Rotterdam), Kengo Tanabe, Yuki Katagiri(University of Amsterdam), Shimpei Nakatani(Erasmus MC), Hiroki Tateishi(Erasmus University Rotterdam), Yoshihiro Morino(Iwate Medical University), Yukio Ozaki(Fujita Health University), Takayuki Okamura(Yamaguchi University)
Cited by 32
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k